KOHJIN BIO CO LTD (177A.T)

JPY 1657.0

(3.05%)

Operating Income Summary of KOHJIN BIO CO LTD

  • KOHJIN BIO CO LTD's latest annual operating income in 2023 was 596.82 Million JPY , down -52.91% from previous year.
  • KOHJIN BIO CO LTD's latest quarterly operating income in 2023 FY was 596.82 Million JPY , down -52.91% from previous quarter.
  • KOHJIN BIO CO LTD reported an annual operating income of 1.26 Billion JPY in 2022, up 30.73% from previous year.
  • KOHJIN BIO CO LTD reported an annual operating income of 969.58 Million JPY in 2021, down 0.0% from previous year.
  • KOHJIN BIO CO LTD reported a quarterly operating income of 225.84 Million JPY for 2023 Q4, down 0.0% from previous quarter.
  • KOHJIN BIO CO LTD reported a quarterly operating income of 1.26 Billion JPY for 2022 FY, up 30.73% from previous quarter.

Annual Operating Income Chart of KOHJIN BIO CO LTD (2023 - 2021)

Historical Annual Operating Income of KOHJIN BIO CO LTD (2023 - 2021)

Year Operating Income Operating Income Growth
2023 596.82 Million JPY -52.91%
2022 1.26 Billion JPY 30.73%
2021 969.58 Million JPY 0.0%

Peer Operating Income Comparison of KOHJIN BIO CO LTD

Name Operating Income Operating Income Difference
PRISM BioLab Co.,LTD -496.86 Million JPY 220.117%
GNI Group Ltd. 13.1 Billion JPY 95.447%
Linical Co., Ltd. 725.72 Million JPY 17.762%
Trans Genic Inc. 89.43 Million JPY -567.317%
MEDINET Co., Ltd. -1.42 Billion JPY 141.854%
Soiken Holdings Inc. -610 Million JPY 197.839%
Cytori Cell Research Institute, Inc. -772.74 Million JPY 177.234%
AnGes, Inc. -11.96 Billion JPY 104.987%
OncoTherapy Science, Inc. -1.12 Billion JPY 153.25%
Nxera Pharma Co., Ltd. -9.52 Billion JPY 106.265%
Immuno-Biological Laboratories Co., Ltd. 104.29 Million JPY -472.222%
NanoCarrier Co., Ltd. -864.41 Million JPY 169.043%
Carna Biosciences, Inc. -1.11 Billion JPY 153.432%
CanBas Co., Ltd. -1.26 Billion JPY 147.292%
D. Western Therapeutics Institute, Inc. -798.55 Million JPY 174.737%
RaQualia Pharma Inc. -337.36 Million JPY 276.907%
Chiome Bioscience Inc. -1.2 Billion JPY 149.522%
Kidswell Bio Corporation -1.33 Billion JPY 144.686%
PeptiDream Inc. 6.77 Billion JPY 91.188%
Oncolys BioPharma Inc. -1.92 Billion JPY 130.924%
Ribomic Inc. -1.11 Billion JPY 153.469%
SanBio Company Limited -4.53 Billion JPY 113.149%
Healios K.K. -3.37 Billion JPY 117.663%
BrightPath Biotherapeutics Co., Ltd. -1.15 Billion JPY 151.669%
Kubota Pharmaceutical Holdings Co., Ltd. -1.39 Billion JPY 142.829%
Delta-Fly Pharma, Inc. -1.4 Billion JPY 142.539%
StemRIM -2.07 Billion JPY 128.749%
CellSource Co., Ltd. 1.22 Billion JPY 51.14%
FunPep Company Limited -994 Million JPY 160.042%
Kringle Pharma, Inc. -888.76 Million JPY 167.152%
Stella Pharma Corporation -760.3 Million JPY 178.498%
TMS Co., Ltd. -943.25 Million JPY 163.273%
Noile-Immune Biotech Inc. -775.39 Million JPY 176.97%
Cuorips Inc. -588.48 Million JPY 201.416%
K Pharma,Inc. 366.05 Million JPY -63.041%
Takara Bio Inc. 3 Billion JPY 80.126%
ReproCELL Incorporated -409.29 Million JPY 245.818%
PhoenixBio Co., Ltd. 11.06 Million JPY -5294.757%
StemCell Institute Inc. 413.75 Million JPY -44.244%
Japan Tissue Engineering Co., Ltd. 144.5 Million JPY -313.006%
CellSeed Inc. -697.77 Million JPY 185.532%